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Abstract: 
Rationale, aims and objectives: The potential bias introduced by surgeons' lack of comparable, 
relevant experience when performing the procedures in different arms of randomised controlled trials 
(RCTs) is arguably not well-managed or reported. The aim of this work was to review the frequency 
DQGQDWXUHZLWKZKLFKVXUJHRQV¶relevant experience is reported in RCTs of total hip (THA) and total 
knee arthroplasty (TKA), and to relate this to other risk of bias domains for this study design. 
Methods: A systematic review of RCTs comparing different minimally invasive procedures for TKA 
and comparisons of THA and hemiarthroplasty (HA). We searched MEDLINE, EMBASE, Science 
Citation Index, The Cochrane Library, Conference Proceedings Citation Index- Science (CPCI-S), 
Current Controlled Trials and Clinical Trials.gov. 
Results: 75 relevant RCTs were identified, 65 RCTs comparing minimally invasive with standard or 
other minimally invasive approaches to TKA, and 10 for THA compared with HA.  Risk of bias based 
RQWKHUHSRUWHGGHWDLOVRIVXUJHRQV¶UHOHYDQWexperience was categorised as low, high or unclear. There 
was a clear distinction before and after 2009, with a substantial decrease in trials at high or unclear risk 
of bias after this date. There were no strong associations between this domain and other, standard risk 
of bias domains for RCTs.  
Conclusion: The surgHRQV¶UHOHYDQWH[SHULHQFHLQDQHYDOXDWHGSURFHGXUHLVRIWHQSRRUO\reported but 
has improved since 2009. The variable is not adequately captured by any other risk of bias domain. 
Future work should concentrate on conducting research on a much larger sample of studies and in 
procedures other than knee and hip arthroplasty. 
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1. INTRODUCTION 
'Bias' is a systematic error affecting the internal validity and results of a study; it can operate in either 
direction (leading to under- or overestimation of an intervention's effect) and can vary in magnitude 
(the potential confounding effect might be small or large)[1]. Bias can also be difficult to quantify, so 
assessments are usually made in terms of the µrisk of bias¶. Such assessments are undertaken to 
determine how close the reported results of a trial are to the 'truth' of the relative efficacy or safety of 
any interventions being tested[1]. The relative efficacy of different interventional procedures is 
commonly assessed in randomised controlled trials (RCTs). However, while other potential 
confounders and sources of bias that might compromise the internal validity of a trial can be controlled 
for by randomisation and allocation concealment (e.g. such as GLIIHUHQFHV LQ SDWLHQWV¶ DJH JHQGHU
condition severity, comorbidities etc.) or the blinding of patients or clinical outcome assessors, the 
potential effect of trial surgeons¶ ability to perform the two procedures or techniques to exactly the same 
standard (even though one technique might be quite novel) is arguably not managed to the same 
degree[2]. 
In order for a comparison to be valid (all other confounders being controlled for), the surgeons 
performing the procedure in each arm of an explanatory randomized controlled trial must be equally or 
adequately adept at each of the respective techniques[2]. Otherwise, for example, one procedure might 
appear relatively much less efficacious or safe than another simply because of a relative lack of relevant 
experience between the surgeons performing the procedures in the two arms of a trial. Such 
considerations must also take into account that one procedure might be more technically challenging 
than the other[2]. 7KHVXUJHRQV¶experience might therefore be considered an additional source of bias 
in trials of interventional procedures;[2, 3] this has been FDOOHGµGLIIHUHQWLDOH[SHUWLVHELDV¶[2]. 
Indeed, there is a sizeable body of literature on the learning curve associated with surgical techniques 
(i.e. the more relevant experience the surgeon has in a technique, the more accurate the outcomes for a 
technique DQG FRQVHTXHQWO\ VXUJHRQV¶ experience in certain interventional procedures is an 
acknowledged potential confounder of outcomes[4-9]. Currently, this is not explicitly taken into 
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account or assessed by any standard critical appraisal tool for RCTs, even in tools specifically for 
critically appraising trials of surgical or interventional procedures[3, 10]. A previous systematic review 
has appraised the reporting of RCTs of surgical interventions, including descriptions of the participating 
surgeons, but GLGQRWFRQVLGHUWKHUHODWLYHGLIIHUHQFHLQVXUJHRQV¶relevant experience across arms or 
how this might introduce bias into the trial[10]. A more recent review has considered the possibility of 
µH[SHUWLVHELDV¶ within spinal surgery RCTs: it found very limited reporting of this variable and did not 
seek to assess its impact[11]. The aim of this current review, therefore, is to assess the reporting and 
SRWHQWLDO LPSDFWRIVXUJHRQV¶relevant experience in RCTs of total hip arthroplasty (THA) and total 
knee arthroplasty (TKA). These procedures have been chosen because it has been demonstrated that 
there is a particular learning curve associated with arthroplasty techniques, which can require the 
performance of a minimum number of procedures (50) if a surgeon is to be considered to have sufficient 
µUHOHYDnt experience¶[6, 12]. However, there is no definitively accepted threshold for prior cases for all 
of the procedures being assessed, so such a number could not be applied universally across trials 
(although numbers were sometimes reported). Nevertheless, an assessment of perceived necessary 
experience in respective techniques could still be made, and this is the focus of this review. 
 
Two recent reviews form the basis of this work and identified sufficient numbers of RCTs for the 
foundation of this exploratory study: one review compared total hip arthroplasty with 
hemiarthroplasty[13] and one compared subvastus (SV), midvastus (MV) or quadriceps-sparing (QS) 
approaches with medial parapatellar (MP) approaches to total knee arthroplasty (TKA)[14]. These 
reviews included eight and 32 RCTs respectively. The current systematic review updates these two 
reviews by identifying more recently-published, relevant RCTs, in order to compile the sample for this 
analysis. These procedures have been chosen because the reviews indicated that there was an adequate 
evidence base of RCTs for assessment, and because WKH VXUJHRQ¶V experience variable has been 
considered briefly in one of the reviews but was not the subject of analysis[13]. The protocol for this 
systematic review is registered with PROSPERO (CRD42017056755). This systematic review seeks to 
answer the following question: wKDWLVWKHIUHTXHQF\DQGQDWXUHRIWKHUHSRUWLQJRIVXUJHRQV¶relevant 
5 
 
experience in RCTs of total hip and total knee arthroplasty and is there an association between risk of 
ELDV EDVHG RQ VXUJHRQV¶ UHOHYDQW H[SHULHQFH DQG ULVN RI ELDV DFURVV RWKHU GRPDLQV (e.g. selection, 
performance or detection bias), as well as between this variable and outcomes? 
 
2. METHODS 
A systematic review of the evidence was undertaken and reported following the general principles 
recommended in the PRISMA statement (http://www.prisma-statement.org/). Inclusion criteria are 
outlined in Table 1. The protocol for the review was registered in the PROSPERO database 
(CRD42017056755). 
 
<insert Table 1: Inclusion criteria> 
 
2.1 Search strategy 
7KLVUHYLHZZDVWRLQFOXGHDOORIWKH5&7VLQFOXGHGLQWKHWZRµIRXQGDWLRQ¶UHYLHZV[13, 14], as well 
as any additional relevant RCTs published since the conduct of those reviews. Two sets of searches of 
electronic databases were undertaken. Comprehensive searches were undertaken to identify RCTs, 
systematic reviews and meta-analyses comparing total hip arthroplasty and hemiarthroplasty in patients 
with fractures of the femoral neck. This involved combining terms for total hip arthroplasty and 
hemiarthroplasty with terms for RCTs and systematic review or meta-analysis. An example MEDLINE 
search strategy is reported in Appendix 1. The aim of the strategy was to identify all trials and reviews 
comparing total hip arthroplasty with hemiarthroplasty published since 2010 (the date of the searches 
performed for the first review[13]). The same process was also followed to identify all trials or reviews 
comparing TKA approaches published since 2013 (the date of the searches performed for the second 
review[14]). The following electronic databases were searched from 2010 or 2013 to February 2017, 
depending on the intervention, for published and unpublished research evidence: 
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 MEDLINE (via Ovid)  
 EMBASE (via Ovid)  
 Science Citation Index (via ISI Web of Science)  
 The Cochrane Library including the Cochrane Systematic Reviews Database, Cochrane 
Controlled Trials Register, DARE, HTA and NHS EED databases  
 Conference Proceedings Citation Index- Science (CPCI-S) (via ISI Web of Science)  
 Current Controlled Trials: https://www.isrctn.com/  
 Clinical Trials.gov up: https://clinicaltrials.gov/  
All citations were imported into Endnote® and duplicates deleted.  
 
2.2 Study selection 
All titles and abstracts of unique citations were screened independently by two reviewers (CC, FM) 
using the inclusion criteria outlined in Table 1. Full papers were retrieved of any citation identified by 
at least one reviewer as being potentially relevant. These full papers were then screened for inclusion 
by both reviewers and any disagreement resolved by consensus. The reference lists of all relevant, 
identified systematic reviews or meta-analyses were also checked for additional trials; cross-referencing 
with RCTs identified as relevant by the database searches was performed. Only full publications were 
included in the review EHFDXVHGHWDLOVRIVXUJHRQV¶H[SHULHQFHZHUHRQO\OLNHO\WREHFRYHUHGLQIXOO
publications. HowHYHUDEVWUDFWVDQGUHFRUGVRIµunpublished¶ trials (from registers) were also checked 
to trace any potentially relevant trials that were not identified by the conventional search. 
 
 
2.3 Data extraction and critical appraisal 
7 
 
After piloting the form on three trials by two reviewers (CC, FM), data were extracted from all included 
studies by one reviewer (FM) and checked by a second (CC) and any discrepancies were resolved by 
discussion. Data were extracted from the full papers of all included RCTs (data previously extracted in 
WKHµIRXQGDWLRQ¶UHYLHZV were not used). The following data were extracted: brief characteristics of the 
included RCTs, including location, population, intervention and comparator details; the number of 
surgeons; their reported experience; any efforts made to control for the variable of surgeons' relevant 
experience; and any available data on the outcomes listed in Table 1. Quality assessment of included 
RCTs was undertaken by two reviewers using the Cochrane risk of bias tool[1]; any disagreements were 
resolved by consensus.  
 
6XUJHRQ¶VH[SHULHQFH 
In order to simplify the data and to render them comparable with other (Cochrane) risk of bias domains 
ORZKLJKDQGXQFOHDUWKHGHVFULSWLRQRIWULDOVXUJHRQV¶H[SHULHQFHZDVFDWHJRULVHGLQWRIDLUO\FUXGH
but distinct and differing levels of risk of bias (see Table 2). This ranged from publications that reported 
GHWDLOVRIWKHLQFOXGHGVXUJHRQV¶H[SHULHQFHLQWKHUHOHYDQWSURFHGXUHVand/or whether an explicit or 
implicit effort was made to control for this variable between arms (and therefore designated for the 
SXUSRVHVRIWKLVVWXG\DVEHLQJDWµORZULVNRIELDV¶WR those that report who did the surgical procedures 
but did not report on WKHRSHUDWLQJVXUJHRQV¶UHOHYDQWH[SHULHQFHµKLJKULVNRIELDV¶DQGWRWKRVHZKHUH
the publication made no mention DWDOORIWKHVXUJHRQV¶H[SHULHQFHLQHLWKHUSURFHGXUHµXQFOHDUULVNRI
ELDV¶,OOXVWUDWLYHH[DPSOHVRIHDFKFDWHJRU\DUHSURYLGHGLQ7DEOH2. The authors considered this to be 
a reasonable categorisation for distinguishing between the level of relevant detail reported by the trial 
publications. 
 
<insert Table 2: Categories of risk of bias based on reported experience of surgeon(s) performing the 
procedures> 
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2.5 Data analysis 
Key data were tabulated and discussed in a narrative synthesis.  These data enabled an assessment of 
the prevalence and nature of reporting of surgeons' relevant experience in these trials. Analyses were 
also undertaken using a simple chi-squared test to investigate whether there was an association between 
the suggested risk of biDVEDVHG RQ VXUJHRQV¶ relevant experience and the risk of bias across other 
domains (e.g. selection, performance or detection bias): i.e. what was the likelihood of trials categorised 
DVEHLQJDWORZULVNRIELDVIRUVXUJHRQV¶UHOHYDQWH[SHULHQFHDOVREHLQg categorised as being at low risk 
of selection bias? This was performed to assess whether other domains (such as selection bias), which 
are currently included in standard checklists, actually capture the potential risk of bias arising from 
uncertainty surrounding the adequately comparable delivery RI WKH WZR µLQWHUYHQWLRQV¶ by surgeons. 
Where the trial evidence was sufficiently homogeneous, and appropriate outcome data were reported 
(e.g. means and standard deviations [SDs] for continuous data), included studies were combined in a 
meta-analysis using a random effects model (RevMan® version 5.1) for determine possible impact of 
the surgeon variable on outcomes. For TKA comparisons, only outcomes with 10 or more relevant 
studies were meta-analysed. The standardised mean difference was reported for continuous data and 
risk ratios (RRs) for dichotomous data (e.g. revision or dislocation event rates). Statistical heterogeneity 
between trials was assessed using the I2 statistic. Separate meta-analyses were performed for relevant 
outcomes, where the data permitted, based on the surgical approach being undertaken, e.g. minimally 
invasive (MV, SV or QS) compared with standard medial parapatellar (MP) approaches, or for total hip 
arthroplasty compared with hemiarthoplasty, with sub-groups based on the different levels of risk of 
ELDVEDVHGRQVXUJHRQV¶UHSRUWHGH[SHULHQFH7KLVHQDEOHGDQH[SORUDWRU\DVVHVVPHQWRIWKHSRWHQWLDO
impact of surgeons' experience on outcomes. Results of these analyses were tabulated. 
 
 
 
 
3. RESULTS 
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3.1 Quantity of evidence 
The searches of the electronic databases retrieved 354 unique citations, of which 108 were relevant to 
this review. After checking relevant systematic reviews and meta-analyses, the final number of relevant 
RCTs was 75 (a full list of these included trials is available in Appendix 2).  The processes of inclusion 
and exclusion are reported in the PRISMA flowchart in the Figure. A full list of excluded studies, with 
reasons, is provided in Appendix 3.  
 
<insert Figure: PRISMA flowchart> 
 
There were 65 RCTs comparing minimally invasive with standard or other minimally invasive 
approaches to TKA. Details of these trials are summarised in Table 3, including the risk of bias category 
assigned to each trial based on the UHSRUWHG GHVFULSWLRQ RI WKH VXUJHRQV¶ UHOHYDQW H[SHULHQFH. This 
represented 34 new TKA RCTs that were not included in the 2014 review (one trial from that review 
was excluded here because it was published in Chinese[15]). With a single exception[16], all of the 
µQHZ¶TKA trials were identified by the search of electronic databases and verified by cross-referencing 
with published systematic reviews and meta-analyses. In terms of the trial evidence for TKA, the 
principal comparisons were different or novel minimally invasive approaches to knee arthroplasty, 
especially mini-vastus (MV), sub-vastus (SV) or quadriceps-sparing (QS) approaches, compared with 
the standard medial parapatellar (MP) approach. 32 RCTs compared MV with MP approaches, 21 
compared SV with MP approaches, six compared QS and MP approaches, and 10 conducted other 
comparisons (e.g. MS vs SV, QS vs SV, MP with and without patellar eversion). 
 
<insert Table 3: Basic characteristics of included RCTs and risk of bias categorisation according to the reported 
expertise of surgeons> 
 
The number of surgeons in any trial ranged from one (32 studies) to seven[12] in the TKA trials, and 
from two[17, 18] to as many as 14[19] in the THA trials. 51% (32/65) of TKA trials had only one 
surgeon. There were 10 RCTs of total hip arthroplasty compared with hemiarthroplasty (this represented 
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the publication of only two new relevant RCTs[17, 18] since the 2011 systematic review[13]), details 
of which are also summarised in Table 2. %RWKRI WKH µQHZ¶ trials were identified by the search of 
electronic databases and verified by cross-referencing with published systematic reviews and meta-
analysis. 
 
3.2 6XUJHRQV¶H[SHULHQFH 
Overall, the majority of RCTs included in this sample were assessed as being at high or unclear risk of 
bias on this variable (see Table 3): 39/65 TKA trials (60%) and 5/10 hip arthroplasty trials (50%) (11 
of the 13 trials at µ8QFOHDU risk of bias¶ did not even report the number of surgeons conducting the 
procedures). Therefore, only 26 TKA RCTs (40%) and 5 hip arthroplasty RCTs (50%) were deemed to 
be at low risk of bias. It should be noted that the reporting of thHµVXUJHRQV¶UHOHYDQWH[SHULHQFH¶ domain, 
especially in the TKA trials, appears to improve from 2009 onwards, the date when the CONSORT 
statement extension for nonpharmacological trials was published, i.e. CONSORT-NPT[3]). Compared 
with 2008 or before, the proportion of TKA RCTs FDWHJRULVHGDVEHLQJDWµORZ¶ULVNRIELDVincreases 
from 17% to 46%; the proportion of trials categorised as being at a µhigh¶ risk of bias decreases from 
WRDQGWKRVHDWµXQFOHDU¶ULVNRIELDVIURPWRVHH7DEOH4).  
 
<insert Table 4: Number of RCTs and risk of bias categorisation by date (median)> 
 
The data suggests that there were changes in reporting standards over time within this sample, with a 
clear trend in improved reporting of surgeonV¶ relevant experience as part of the trial. There are small 
changes in reporting standards within the hip arthroplasty RCT sample over time also, with a small 
trend in improved reporting and control of surgeonV¶ relevant experience as part of the trial. Finally, 
there was no specific pattern by country for either TKA or total hip arthroplasty (without taking into 
account date). 
 
,QRIWKHLQFOXGHGWULDOVQRGHWDLOVZHUHUHSRUWHGDWDOOFRQFHUQLQJWKHRSHUDWLQJVXUJHRQV¶
relevant experience in performing the respective procedures, i.e. therefore deemed to be at high or 
11 
 
unclear risk of bias for this variable. There were some differences between trials depending on the 
procedures being evaluated (trials of SV TKA tended to be at lower risk of bias for this domain), but 
most noticeably there is a clear trend by date, with more recent trials tending to be better reported and 
therefore at lower risk of bias for this domain (see Table 4). 6RPHRIWKHWULDOVLQWKHµORZULVNRIELDV¶
FDWHJRU\PLJKWHYHQEHFRQVLGHUHGHTXLYDOHQWLQVRPHZD\VWRWKHµH[SHUWLVH-EDVHG5&7V¶GHVFULEHG
elsewhere[2]. However, not all recently-published trials adequately report the key details (53% of TKA 
trials published in 2009 or later are all still at a high or unclear risk of bias for this domain: see Table 
4). 
 
Where the data were appropriate for pooling, the results of a series of analyses are reported in Table 5. 
The choice of analyses was determined by the availability and appropriateness of the data (e.g. the 
provision of means and standard deviations for continuous outcomes) so, despite the potentially 
substantial number of trials for inclusion (up to 65 for the TKA sample), only data from between 13 
and 20 trials could be pooled in any meta-analysis. There was a high degree of statistical heterogeneity 
in the sample for each analysis of TKA trials, but low or moderate statistical heterogeneity in the sample 
of hip trials. For the TKA trials, there were no significant differences in any outcome between trials at 
high or unclear ULVNRIELDVEDVHGRQWKHVXUJHRQV¶UHSRUWHGH[SHUWLVHDQGWKRVHDWORZULVNRIELDVRQ
this variable (all confidence intervals overlapped).  
 
<insert Table 5> 
 
However, with the exception of blood loss, the findings from the pooled data of the studies at low risk 
of bias were much more uncertain, i.e. had much wider confidence intervals, than the findings for those 
studies considered to be at high or unclear risk of bias on this variable. Forest plots for these analyses 
are available in Appendix 4. 
 
3.3 Other risk of bias domains  
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Only the following domains were assessed: selection bias (randomisation and allocation concealment), 
performance bias (patient blinding) and detection bias (blinding of outcome assessors).  Unlike drug 
trials, sealed (and opaque) envelopes were often used as both a means of randomisation and allocation 
concealment in these trials of surgical procedures. In this sample, 35% of trials (26/75) reported using 
this method and, despite known issues with sealed envelopes, it can be a robust method of both 
randomisation and allocation concealment[1]. The results of the critical appraisal of all included trials 
are presented in Table 6 for both the TKA and hip arthroplasty RCTs. 
 
<insert Table 6: Risk of bias for other domains> 
 
Blinding of patients can also be a problem for comparative studies of certain surgical procedures[20]. 
However, in this sample (across the principal comparisons) it appears to have been possible because a 
number of trials report making efforts to ensure blinding of patients and outcome assessors by indicating 
that the incision made for the comparative procedures was in the same location and of the same 
length[16, 21-27]. However, such inconsistency in the conduct and reporting of blinding has been 
demonstrated in surgical trials previously[20]. 
 
Assessments of µreporting bias¶ are not presented here for two reasons. First, this domain has been 
recognised as problematic in its assessment and the application of its findings to synthesis[28]. Second, 
unlike drug trials, this sample of trials of surgical interventions usually did not register any protocol, so 
no reliable or valid assessment could be made of whether there was complete consistency between 
intended and published outcomes[1]. In only three studies (4%)[29-31] were any outcomes reported in 
the Results that were not specified in the Methods. As a result, almost all trials would have been assessed 
as being at low risk of bias for this domain. The generally low risk of bias across the domains relating 
to detection and attrition bias (findings for the latter not reported here) might be a reflection of the small 
number of patients in trials, their generally short or very short follow-ups (few TKA trials had follow-
ups longer than 12 months) and the relative ease of blinding assessors to interventions compared with 
the practical problems inherent in minimising or nullifying learning curve effects. 
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It is apparent that the evidence base for the comparison of THA and HA was generally of low quality, 
with a high risk of bias across most domains (except attrition bias, data not reported), similar to the risk 
of bias inheUHQWLQWKHGRPDLQRIVXUJHRQV¶UHOHYDQWexperience (see Tables 3 and 6). Based on this 
sample, the standards of reporting of surgical RCTs, across most of these domains, appear to have 
improved in recent years[32]. It is noteworthy, however, that the trend for improved reporting is also 
apparent across this sample of TKA RCTs for other risk of bias domains, for example randomisation 
(see Table 6). 
 
Chi-squared tests did find significant associations, but only at the p<0.05 level, between risk of bias due 
to the reported details of VXUJHRQV¶ relevant experience and risk of bias due to both allocation 
concealment (X2 statistic 5.07, p=0.024) and attrition bias (X2 statistic 7.82, p=0.05). This suggests that, 
when the risk of bias was FDWHJRULVHGDVORZIRUWKHµVXUJHRQV¶GRPDLQWKHQit was also categorised as 
low for these other two domains. However, there was no association at all for randomisation (X2 statistic 
2.43, p=0.119) or detection bias (X2 statistic 1.40, p=0.237). Therefore, there does not appear to a 
particularly strong association in this sample between the risk of bias assessed as being due to the 
VXUJHRQV¶UHOHYDQWH[SHULHQFHDQGWKHULVNRIELDVDVDGMXGJHGIRURWKHUGRPDLQVPerformance bias, as 
determined by patient blinding, was not assessed as this was often unclear.   
 
DISCUSSION 
7KHVWDQGDUGVRIUHSRUWLQJUHJDUGLQJVXUJHRQV¶UHOHYDQWexperience in performing the procedures being 
assessed in total knee and total hip arthroplasty trials is not very good, but does appear to be better than 
that reported elsewhere. For example, in this sample, 77% (58/75) of the trials reported the number of 
surgeons involved, which compares favourably with only 32% (51/158) in a previous review of RCTs 
of various surgical interventions from 2004[10].  In this sample the trend is certainly towards improved 
reporting of deWDLOVUHJDUGLQJVXUJHRQV¶UHOHYDQWH[SHULHQFH, as well as other risk of bias domains, such 
as randomisation procedures, a trend which had not always been found with reporting of surgical RCTs 
more generally[10, 33]. This trend is further highlighted by comparison with previous reviews. In a 
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similar review, but of open spinal surgery RCTs published between 2005 and 2010, only 10% (10/99) 
reported any details about the operating surgeons¶ experience or expertise[11], while another review, 
published in 2006[10], reported that the surgeons were described only DVµH[SHULHQFHG¶ in 19% of the 
trials, with only 11% reporting a surgeon as having experience of the experimental intervention. This 
compares with the 37% (28/75) of the current sample, categorised as being at low risk of bias on account 
of thH DFNQRZOHGJPHQWRI µH[SHULHQFH¶ (see Table 4). In this previous review, in terms of reported 
HIIRUWVWRµVWDQGDUGLsH¶SURFHGXUHV, only 6% of trials reported supervision by a senior surgeon, and 1% 
the use of protocol guidelines and video assessment[10]. However, it is unclear if these procedures were 
performed with the intention of standardising practice across centres or specifically to facilitate 
FRPSDUDELOLW\RIVXUJHRQV¶relevant experience across all of the procedures being evaluated. The former 
is suggested by other applications of the CONSORT-NPT checklist[34]. Even if it did indicate the 
reporting of DWWHPSWVWRµVWDQGDUGLsH¶OHYHOVRIVXUJHRQV¶relevant experience across arms, the reported 
rates were certainly much lower (no more than 6%) than in this sample of TKA and THA RCTs (37%). 
 
The reason for the improved reporting of this domain from 2009 onwards is not entirely clear, but might 
be due in some part to the publication in 2008 of the CONSORT-NPT statement extension[3]. This 
checklist was produced with surgical interventions, amongst others, in mind, and raises the issues of 
VXUJHRQV¶ relevant experience in procedures, as well as differences in procedures in terms of their 
difficulty. Consequently, it recommends reporting ³'HWDLOV RI KRZ WKH LQWHUYHQWLRQV ZHUH
standardizHG´[3]. None of the trials included in this sample actually reference this statement (only eight 
of the 44 papers published in 2009 or later make any reference to CONSORT at all, and then just in 
relation to the provision of a flowchart of participants[35-42], but there might be a general, tacit 
influence of improved reporting standards at play. Finally, there are significant associations between 
JRRGRUSRRUUHSRUWLQJRIWKHVXUJHRQ¶Vexperience domain and good or poor reporting of allocation 
concealment and attrition within this set of RCTs, but there are no other significant associations between 
the surgeon domain and others. The absence of strong associations might be due to the sample being 
underpowered, but it might also be due to the fact that existing risk of bias domains in checklists and 
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tools simply do not adequately capture the issue of comparable levels of relevant experience among 
trial surgeons.  
  
The meta-analyses did not demonstrate any meaningful differences between the findings of trials at 
high or unclear risk of bias compared with trials at low risk of bias, except that the latter did tend to 
produce findings of relatively greater uncertainty across four of the five outcomes in this sample. This 
outcome accords with other evidence that better-FRQGXFWHG WULDOVFDQWHQG WRSURGXFHOHVVµSRVLWLYH¶
findings.[43] However, the results here must be considered very cautiously given the small number of 
trials within the respective subgroups. Interpretation of these findings is made more difficult still 
because it must take into account the possibility that, given the technical challenges of some procedures, 
longer operating time, for example, might indicate a better-performed procedure.[2, 3] 
 
This study must be considered exploratory only, given that the sample of trials included in the 
systematic review is not large (less than 100). This study also only focused on RCTs of two particular 
procedures, knee and hip arthroplasty, so its findings might not apply to the reporting and impact of 
VXUJHRQV¶relevant experience in trials of other procedures, although the reporting in this sample does 
compare favourably with the results of a systematic review assessing reporting in a sample of RCTs of 
various procedures which were published in 2004[10]. It should be noted that even with efforts to 
FRQWUROIRUVXUJHRQV¶relevant experience, one technique might always be more challenging than another 
and thus present problems of comparability[2]. However, this issue will only be relevant to particular 
types of trials, such as those evaluating something new or especially challenging. Its value is more 
debatable in the assessment of a trial that is comparing two standard, but previously not compared 
treatments, or just comparing a modification of a standard treatment. Finally, any assessment of risk of 
bias across many of the domains covered here is in part interpretive and relies on the reporting of these 
HOHPHQWV LQ WKHSDSHUV7KH UHSRUWLQJRIVXUJHRQV¶ experience in these 75 papers is relatively poor, 
despite evidence of adequate reporting across some other risk of bias domains in these trials. It might 
therefore be the case that efforts were made to control for this potential confounder, but not fully 
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reported. After all, it has been suggested elsewhere that authors might fail to report certain elements of 
surgical trial conduct, even though they were adequately performed[44]. 
 
Nevertheless, this is the first systematic review to seek to assess both the reporting and relevance of this 
variable; the chosen procedures are known to be particularly vulnerable to a learning curve[6, 12]; and 
the sample is of moderate size and almost certainly includes all known, relevant RCTs comparing 
relevant procedures from the last 20 years. This study also adhered to published international standards 
in the conduct and reporting of systematic reviews. The risk of bias explored in this review, i.e. between-
arm differentials LQVXUJHRQV¶experience, PLJKWEHFRQVLGHUHGWREHµHVVHQWLDOLQIRUPDWLRQDERXt the 
LQWHUYHQWLRQ¶[45], which should be reported if an appropriate assessment of the bias potentially affecting 
DWULDO¶VRXWFRPHVLVWREHFRQGXFWHG,WPLJKWHYHQEHFRQVLGHUHGDZRUWKZKLOHµFODULI\LQJ¶addition to 
the intervention description component of the CONSORT-NPT extension statement[3], adherence to 
which is known to be inadequate but is being strongly encouraged[46, 47]. 
 
Differences in the relevant experience of the surgeons performing the procedures being compared in a 
randomised controlled trial is a recognised potential confounder of a WULDO¶VUHVXOWV[3, 6, 12]. This review 
of trials of total knee and total hip arthroplasty has demonstrated that this variable is often poorly 
reported, although there is a trend towards improved reporting since 2009, and that it is not adequately 
captured by any other risk of bias domain. It is therefore worthy of assessment. Future work should 
concentrate on conducting research on a much larger sample of studies and in procedures other than 
knee and hip arthroplasty. 
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FIGURE LEGENDS: 
PRISMA flowchart 
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Total number of hits 
N=651 
Number after de-duplication 
n=354 
Titles / abstracts excluded  
n=237 
Total number of full papers and 
abstracts included 
n=108 
Full papers and abstracts checked 
n=157 
Exclusions n=49 
Not RCT/SR n=12 
Protocol only n=3 
Incorrect PICO n=15 
Letter n=4 
Language other than English n=7 
Retracted publication n=2 
Duplicate n=6 
 
Hip arthroplasty SRs, papers and 
abstracts n=33 
Included RCTs n=10 
 
 
Knee arthroplasty SRs, papers and 
abstracts n=76 
Included RCTs n=65* 
 
Studies from foundation reviews 
n=40 
Reference tracking 
n=1 
SR: Systematic Review; PICO: Population, Intervention, Comparator, Outcomes; RCT: Randomised Controlled Trial 
*Includes 13 RCTs with TKA comparisons other than MV vs MP or SV vs MP 
Figure: PRISMA flowchart 
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Table 1: Inclusion criteria 
 
Criteria 
 
Total Knee Arthroplasty review 
 
Total Hip Arthroplasty review 
 
Population 
 
Adult patients eligible for total knee 
arthroplasty 
 
 
Adult patients eligible for total hip 
replacement 
 
 
Intervention 
 
Total Knee Arthroplasty (TKA) 
 
Total Hip Arthroplasty (THA) 
 
 
Comparators 
 
Any alternative TKA technique 
 
 
Hemiarthroplasty (HA) 
 
Outcomes 
 
Primary outcomes: 
 Pain score by Visual Analog Score 
(VAS) 
 Knee Society Score (KSS)  
 knee range of motion (ROM) 
Secondary outcomes: 
 Mortality 
 Operative time (in minutes) 
 Blood loss 
 Length of hospital stay. 
 Post-operative complications 
 
 
Primary outcomes: 
 Dislocation rate 
 Revision rate 
 
 
Secondary outcomes: 
 Mortality 
 Operative time (in minutes) 
 Blood loss 
 Length of hospital stay. 
 Post-operative complications 
 
Study design 
 
Randomised controlled trials (RCTs), systematic reviews or meta-analyses of RCTs 
 
 
Follow-up 
 
No minimum duration of follow-up 
 
 
Language 
 
Only studies published in English will be included because of the need to read the report 
in detail 
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Table 2: Categories of risk of bias based on reported experience of surgeon(s) performing the 
procedures 
Risk of Bias Definition Example 
Low  Clear reference is made to 
the surgeons¶ relevant 
experience in the particular 
procedures and/or an explicit 
or implicit effort is made to 
control for this variable 
between arms 
 
 
 
³All operations were performed by the senior surgeon « The 
senior surgeon had performed more than 100 total knee 
arthroplasties using each of the two approaches (MV and SV) 
prior to starting this study´20  
 
³All operations were perfoUPHG E\ WKH ILUVW DXWKRU « The 
operating surgeon had performed >1000 total knee 
arthroplasties using the mini-midvastus approach and >100 
procedures using the mini-subvastus approach prior to the start 
of this study´21 
High No reference is made to 
surgeons¶ relevant 
experience in the particular 
procedures, but the 
individual(s) performing the 
surgery is reported  
³$OOWKHNQHHVZHUHRSHUDWHGRQE\WKHVDPHVXUJHRQ´24 
 
³$OOVXUJHU\ZDVSHUIRUPHGE\WKHVHQLRUDXWKRU´25 
Unclear No details are provided 
about who conducted the 
surgery 
Nothing reported 
TKA: Total Knee Arthroplasty; MV: Midvastus; SV: Subvastus 
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Table 3:  Basic characteristics of included RCTs and risk of bias categorisation according to the reported experience of surgeons 
 
Author, Year Country Intervention (n=) Comparator (n=) Number of 
surgeons 
Risk of bias 
TKA RCTs 
Weinhardt, 2004 Germany 26 26 1 Low 
Bathis, 2005 Germany 25 25 1 Low 
Seon, 2006 Korea 49 53 1 Low 
Chin, 2007 Singapore 30 30 2 Low 
Bridgman, 2009 UK 116 115 7 Low 
Juosponis, 2009 Lithuania 35 35 2 Low 
Lin, 2009 Taiwan 30 30 1 Low 
Sastre, 2009 Spain 56 48 2 Low 
Bonutti, 2010 USA 51 51 1 Low 
Nestor, 2010 USA 27 27 2 Low 
Pan, 2010 China 35 33 1 Low 
Van Hemert, 2010 Netherlands 20 20 2 Low 
Kim, 2011 Korea 25 25 1 Low 
Tasker, 2014 UK 46 46 3 Low 
Varnell, 2011 USA 20 37 3 Low 
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Author, Year Country Intervention (n=) Comparator (n=) Number of 
surgeons 
Risk of bias 
Varela-Egocheaga, 
2011 
Spain 50 50 1 Low 
Bourke, 2012 Australia 40 41 6 Low 
Masjudin, 2012 Malaysia 23 23 1 Low 
Jain, 2013 India 50 50 1 Low 
Jarvis, 2013 USA 27 26 3 Low 
Wegryzn, 2013 USA 19 18 1 Low 
Verburg, 2016 Netherlands 50 50 2 Low 
Fezcko, 2016 Netherlands, 
Germany, 
Australia 
36 33 3 Low 
 
Engh, 1997 USA 57 61 1 High 
Dalury, 1999 USA 24 24 1 High 
Parentis, 1999 USA 21 21 2 High 
Roysam, 2001 UK 46 43 1 High 
Komatsu, 2003 Japan 10 10 1 High 
Ozkoc, 2005 Turkey 21 21 2 High 
Aglietti, 2006 Italy 30 30 1 High 
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Author, Year Country Intervention (n=) Comparator (n=) Number of 
surgeons 
Risk of bias 
Hart, 2006 Czech Republic 40 40 2 High 
Kelly, 2006 USA 20 27 2 High 
Kolisek, 2007 USA 40 40 Unclear High 
Dalury, 2008 USA 20 20 1 High 
Han, 2008 Korea 15 15 1 High 
Karachalios, 2008 Greece 50 50 1 High 
Arnout, 2009 Belgium 30 30 1 High 
Karpman, 2009 USA 20 19 1 High 
Hay, 2010 Australia, 
Switzerland 
16 16 1 High 
Dutka, 2011 Poland 97 83 1 High 
Lee, 2011 Korea 30 30 1 High 
Matsumoto, 2011 Japan 25 25 1 High 
Guy, 2012 UK 40 40 
 
High 
Pongcharoen, 2013 Thailand 30 30 1 High 
Umrani, 2013 Korea 36 36 1 High 
Thienpont, 2013 Belgium 150 150 1 High 
Zhang, 2013 China 45 44 1 High 
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Author, Year Country Intervention (n=) Comparator (n=) Number of 
surgeons 
Risk of bias 
Aydogdu, 2014 Turkey 15 11 1 High 
Cho, 2014 Korea 33 33 1 High 
Heekin, 2014 USA 20 20 1 High 
Jenkins, 2014 USA 60 60 3 High 
Nutton, 2014 UK 12 16 2 High 
Koh, 2016 Korea 51 51 1 High 
Aslam, 2017 India 42 42 1 High 
 
Faure, 1993 USA 20 20 NR Unclear 
Keating, 1999 USA 50 50 NR Unclear 
Cila, 2002 Turkey 10 12 NR Unclear 
Gelfer, 2003 Israel 15 15 NR Unclear 
Berth, 2007 Germany 20 20 NR Unclear 
Walter, 2007 USA 61 61 2 Unclear 
Hernandez-
Vacquero, 2010 
Spain 30 40 NR Unclear 
Chiang, 2012 Taiwan 40 40 NR Unclear 
Siramunakul, 2012 Thailand 14 14 NR Unclear 
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Author, Year Country Intervention (n=) Comparator (n=) Number of 
surgeons 
Risk of bias 
Reid, 2014 UK, Australia 37 31 2 Unclear 
Tomek, 2014 USA 63 66 NR Unclear 
 
THA vs HA RCTs 
 
Baker, 2006 UK 41 40 NR Low 
Keating, 2006 UK 69 69 Unclear Low 
Blomfeldt, 2007 Sweden 60 60 9 Low 
Van den Bekerom, 
2010 
Netherlands 137 115 Unclear Low 
Cadossi, 2013 USA 41 42 2 Low 
Ravikumar, 2000 UK 91 89 NR High 
Macaulay, 2008 USA 17 23 14 High 
Sharma, 2016 India 40 40 2 High 
Dorr, 1989 USA 50 39 NR Unclear 
Mouzopou- 
lous, 2008 
Greece 43 43 Unclear Unclear 
 
NR: Not reported 
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Table 4: Number of RCTs and risk of bias categorisation by date (median) 
Risk of Bias TKA vs TKA (%) THA vs HA (%) 
1997-2008 2009-2017 1997-2008 2009-2017 
Low 4 (17)  19 (46) 3 (29)  2 (33) 
High 14 (58) 17 (41) 2 (29) 1 (33) 
Unclear 6 (25) 5 (12) 2 (29) 0 (0) 
Totals 24 41 7 3 
 TKA: Total Knee Arthroplasty; THA: Total Hip Arthroplasty; HA: Hemiarthroplasty. Percentages might not be 100 due to 
µURXQGLQJXS¶DQGµURXQGLQJGRZQ¶ 
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Table 5: Results of meta-DQDO\VHVRINQHHDQGKLSDUWKURSODVW\EDVHGRQGRPDLQRI VXUJHRQV¶
reported experience 
 
Total knee arthroplasty 
Outcome Comparison Risk of bias Number 
of  trials 
Mean 
difference 
95% CI p value * I2 statistic 
(%) 
ROM (flexion) MIS vs MP High or 
unclear 
10 -1.34 -3.88, 1.19 0.30 57 
Low 5 4.27 -0.46, 9.00 0.08 87 
Operative time 
PLQXWHV 
MIS vs MP High or 
unclear 
13 5.87 0.52, 11.22 0.03 93 
Low 7 9.92 1.01, 18.83 0.001 90 
Blood loss (ml) MIS vs MP High or 
unclear 
8 -51.77 -218.69, 115.15 0.54 99 
Low 5 -0.64 -65.81, 64.54 0.98 69 
 
Total hip arthroplasty 
Outcome Comparison Risk of bias Number 
of  trials 
Risk ratio 
(RR) 
95% CI p value * I2 statistic 
(%) 
Dislocation THA vs HA High or 
unclear 
3 1.88 1.03, 3.43 0.04 0  
Low 4 5.01 1.33, 18.90 0.32 14 
Revision THA vs HA High or 
unclear 
4 0.39 0.17, 0.86 0.02 7 
Low 4 0.82 0.21, 3.22 0.77 58 
*Test for overall effect; ROM: Range of motion; MIS: Minimally Invasive Surgeries, e.g. MV, SV, QS etc.; CI: Confidence 
Interval; 7+$WRWDOKLSDUWKURSODVW\+$+LSDUWKURSODVW\7RXUQLTXHWWLPHLIQRRWKHUWLPHGDWDZHUHSURYLGHG 
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Table 6: Risk of bias for other domains  
Risk of bias 
domain 
Randomisation Allocation Performance Detection Surgeon 
Author, Year                                                                         TKA RCTs 
Weinhardt, 2004 High High Unclear High Low 
Bathis, 2005 Low Low Low  Low Low 
Seon, 2006 High High Unclear Low Low 
Chin, 2007 Low Low Low Low Low 
Bridgman, 2009 Low Low Low Low Low 
Juosponis, 2009 Low Low Unclear Low Low 
Lin, 2009 Low Low Low Low Low 
Sastre, 2009 Low Low Low Low Low 
Bonutti, 2010 Low Low Unclear Low Low 
Nestor, 2010 High High Low Low Low 
Pan, 2010 Low Low Low Low Low 
Van Hemert, 2010 High High Low Low Low 
Kim, 2011 Low Low Unclear Low Low 
Tasker, 2014 Low Low Unclear Low Low 
Varnell, 2011 High High Unclear High Low 
Varela-Egocheaga, 
2011 
Low High Unclear High Low 
Bourke, 2012 Low Low Low Low Low 
Masjudin, 2012 Low Low Unclear Low Low 
Jain, 2013 Low Low Unclear Low Low 
Jarvis, 2013 High High Unclear High Low 
Wegryzn, 2013 Low High Low Low Low 
Verburg, 2016 Low Low Unclear Low Low 
Fezcko, 2016 High High High Low Low 
 
Engh, 1997 High High Low Low High 
Dalury, 1999 High High Low  Low High 
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Risk of bias 
domain 
Randomisation Allocation Performance Detection Surgeon 
Parentis, 1999 High High High High High 
Roysam, 2001 Low Low Low Low High 
Komatsu, 2003 High High High High High 
Ozkoc, 2005 High High High High High 
Aglietti, 2006 Low Low Low Low High 
Hart, 2006 High High Unclear Low High 
Kelly, 2006 High High High High High 
Kolisek, 2007 Low Low Unclear High High 
Dalury, 2008 Low High Low  Low High 
Han, 2008 Low High Unclear High High 
Karachalios, 2008 Low Low Unclear Low High 
Arnout, 2009 High High High Low High 
Karpman, 2009 Low High Low Low High 
Hay, 2010 Low Low Low Low High 
Dutka, 2011 High High Low Low High 
Lee, 2011 Low Low Unclear Low High 
Matsumoto, 2011 High High Low High High 
Guy, 2012 Low Low Unclear Low High 
Pongcharoen, 2013 Low High Unclear High High 
Umrani, 2013 Low High Unclear Low High 
Thienpont, 2013 High High Unclear High High 
Zhang, 2013 Low High Unclear Low High 
Aydogdu, 2014 High High Unclear Low High 
Cho, 2014 High High High High High 
Heekin, 2014 High High Low High High 
Jenkins, 2014 Low High Low Low High 
Nutton, 2014 Low Low Low Low High 
Koh, 2016 Low Low Low Low High 
Aslam, 2017 Low High Low Low High 
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Risk of bias 
domain 
Randomisation Allocation Performance Detection Surgeon 
 
Faure, 1993 High High Low Low Unclear 
Keating, 1999 High High Low Low Unclear 
Cila, 2002 High High Unclear High Unclear 
Gelfer, 2003 High High Low Low Unclear 
Berth, 2007 Low Low Unclear High Unclear 
Walter, 2007 Low Low Unclear Low Unclear 
Hernandez-
Vacquero, 2010 
Low High High High Unclear 
Chiang, 2012 Low High Low Low Unclear 
Siramunakul, 2012 High High Unclear High Unclear 
Reid, 2014 Low Low Low Low Unclear 
Tomek, 2014 Low Low High Low Unclear 
 
THA vs HA RCTs 
 
Baker, 2006 Low Low Unclear High Low 
Keating, 2006 Low High Unclear Low Low 
Blomfeldt, 2007 Low Low Unclear Low Low 
Van den Bekerom, 
2010 
Low Low Unclear High Low 
Cadossi, 2013 High High Unclear High Low 
Ravikumar, 2000 High High Unclear High High 
Macaulay, 2008 Low Low Unclear High High 
Sharma, 2016 Low High Unclear High High 
Dorr, 1989 High High High High Unclear 
Mouzopou- 
lous, 2008 
High High Unclear Low Unclear 
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